OC06.02: Prognostic value of repeat maternal serum angiogenic markers for prediction of perinatal adverse outcomes in pregnancies with pre‐eclampsia.

The highest stand-alone predictive performance was obtained with sFlt-1/PlGF ratio (AUROC: 0.82, 95% CI: 0.75 - 0.89) and creatinine (AUROC: 0.74, 95% CI: 0.67 - 0.80), while sFlt-1/PlGF ratio was superior to creatinine alone (P < 0.001). The aim of this study was to evaluate the prognostic value of repeat maternal serum angiogenic markers for the prediction of perinatal adverse outcomes in pregnancies with pre-eclampsia. OC06.02: Prognostic value of repeat maternal serum angiogenic markers for prediction of perinatal adverse outcomes in pregnancies with pre-eclampsia. [Extracted from the article]